Global Molecular Diagnostics Point of Care Market Research Report 2024(Status and Outlook)
Report Overview
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report provides a deep insight into the global Molecular Diagnostics Point of Care market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics Point of Care Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics Point of Care market in any manner.
Global Molecular Diagnostics Point of Care Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Abaxis
Bayer Healthcare
Bio-Rad Laboratories
Becton Dickinson and Company
Binx Health
BioMerieux
Co-Diagnostics
DanaherCorporation
Dako
F. Hoffmann
OraSure Technologies
Roche Diagnostics
Nipro Diagnostics
Genestat
Meridian Bioscience
Molbio Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Visby Medical
Wuhan Easy Diagnosis Biomedicine
Beijing Tiandz
Beijing Content
Market Segmentation (by Type)
Assays and Kits
Instruments and Analyzers
Software and Services
Others
Market Segmentation (by Application)
Tumor
Hematology
Endocrinology
Infectious Disease
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics Point of Care Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report provides a deep insight into the global Molecular Diagnostics Point of Care market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Diagnostics Point of Care Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Diagnostics Point of Care market in any manner.
Global Molecular Diagnostics Point of Care Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Abaxis
Bayer Healthcare
Bio-Rad Laboratories
Becton Dickinson and Company
Binx Health
BioMerieux
Co-Diagnostics
DanaherCorporation
Dako
F. Hoffmann
OraSure Technologies
Roche Diagnostics
Nipro Diagnostics
Genestat
Meridian Bioscience
Molbio Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Visby Medical
Wuhan Easy Diagnosis Biomedicine
Beijing Tiandz
Beijing Content
Market Segmentation (by Type)
Assays and Kits
Instruments and Analyzers
Software and Services
Others
Market Segmentation (by Application)
Tumor
Hematology
Endocrinology
Infectious Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Molecular Diagnostics Point of Care Market
- Overview of the regional outlook of the Molecular Diagnostics Point of Care Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics Point of Care Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Molecular Diagnostics Point of Care
1.2 Key Market Segments
1.2.1 Molecular Diagnostics Point of Care Segment by Type
1.2.2 Molecular Diagnostics Point of Care Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics Point of Care Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Molecular Diagnostics Point of Care Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET COMPETITIVE LANDSCAPE
3.1 Global Molecular Diagnostics Point of Care Sales by Manufacturers (2019-2024)
3.2 Global Molecular Diagnostics Point of Care Revenue Market Share by Manufacturers (2019-2024)
3.3 Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Diagnostics Point of Care Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Molecular Diagnostics Point of Care Sales Sites, Area Served, Product Type
3.6 Molecular Diagnostics Point of Care Market Competitive Situation and Trends
3.6.1 Molecular Diagnostics Point of Care Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Diagnostics Point of Care Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS POINT OF CARE INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics Point of Care Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS POINT OF CARE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics Point of Care Sales Market Share by Type (2019-2024)
6.3 Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2019-2024)
6.4 Global Molecular Diagnostics Point of Care Price by Type (2019-2024)
7 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics Point of Care Market Sales by Application (2019-2024)
7.3 Global Molecular Diagnostics Point of Care Market Size (M USD) by Application (2019-2024)
7.4 Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
8 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY REGION
8.1 Global Molecular Diagnostics Point of Care Sales by Region
8.1.1 Global Molecular Diagnostics Point of Care Sales by Region
8.1.2 Global Molecular Diagnostics Point of Care Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Diagnostics Point of Care Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Diagnostics Point of Care Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Diagnostics Point of Care Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Diagnostics Point of Care Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Diagnostics Point of Care Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Molecular Diagnostics Point of Care Basic Information
9.1.2 Abbott Laboratories Molecular Diagnostics Point of Care Product Overview
9.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Molecular Diagnostics Point of Care SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Abaxis
9.2.1 Abaxis Molecular Diagnostics Point of Care Basic Information
9.2.2 Abaxis Molecular Diagnostics Point of Care Product Overview
9.2.3 Abaxis Molecular Diagnostics Point of Care Product Market Performance
9.2.4 Abaxis Business Overview
9.2.5 Abaxis Molecular Diagnostics Point of Care SWOT Analysis
9.2.6 Abaxis Recent Developments
9.3 Bayer Healthcare
9.3.1 Bayer Healthcare Molecular Diagnostics Point of Care Basic Information
9.3.2 Bayer Healthcare Molecular Diagnostics Point of Care Product Overview
9.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product Market Performance
9.3.4 Bayer Healthcare Molecular Diagnostics Point of Care SWOT Analysis
9.3.5 Bayer Healthcare Business Overview
9.3.6 Bayer Healthcare Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Molecular Diagnostics Point of Care Basic Information
9.4.2 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Overview
9.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Becton Dickinson and Company
9.5.1 Becton Dickinson and Company Molecular Diagnostics Point of Care Basic Information
9.5.2 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Overview
9.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Market Performance
9.5.4 Becton Dickinson and Company Business Overview
9.5.5 Becton Dickinson and Company Recent Developments
9.6 Binx Health
9.6.1 Binx Health Molecular Diagnostics Point of Care Basic Information
9.6.2 Binx Health Molecular Diagnostics Point of Care Product Overview
9.6.3 Binx Health Molecular Diagnostics Point of Care Product Market Performance
9.6.4 Binx Health Business Overview
9.6.5 Binx Health Recent Developments
9.7 BioMerieux
9.7.1 BioMerieux Molecular Diagnostics Point of Care Basic Information
9.7.2 BioMerieux Molecular Diagnostics Point of Care Product Overview
9.7.3 BioMerieux Molecular Diagnostics Point of Care Product Market Performance
9.7.4 BioMerieux Business Overview
9.7.5 BioMerieux Recent Developments
9.8 Co-Diagnostics
9.8.1 Co-Diagnostics Molecular Diagnostics Point of Care Basic Information
9.8.2 Co-Diagnostics Molecular Diagnostics Point of Care Product Overview
9.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.8.4 Co-Diagnostics Business Overview
9.8.5 Co-Diagnostics Recent Developments
9.9 DanaherCorporation
9.9.1 DanaherCorporation Molecular Diagnostics Point of Care Basic Information
9.9.2 DanaherCorporation Molecular Diagnostics Point of Care Product Overview
9.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product Market Performance
9.9.4 DanaherCorporation Business Overview
9.9.5 DanaherCorporation Recent Developments
9.10 Dako
9.10.1 Dako Molecular Diagnostics Point of Care Basic Information
9.10.2 Dako Molecular Diagnostics Point of Care Product Overview
9.10.3 Dako Molecular Diagnostics Point of Care Product Market Performance
9.10.4 Dako Business Overview
9.10.5 Dako Recent Developments
9.11 F. Hoffmann
9.11.1 F. Hoffmann Molecular Diagnostics Point of Care Basic Information
9.11.2 F. Hoffmann Molecular Diagnostics Point of Care Product Overview
9.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product Market Performance
9.11.4 F. Hoffmann Business Overview
9.11.5 F. Hoffmann Recent Developments
9.12 OraSure Technologies
9.12.1 OraSure Technologies Molecular Diagnostics Point of Care Basic Information
9.12.2 OraSure Technologies Molecular Diagnostics Point of Care Product Overview
9.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product Market Performance
9.12.4 OraSure Technologies Business Overview
9.12.5 OraSure Technologies Recent Developments
9.13 Roche Diagnostics
9.13.1 Roche Diagnostics Molecular Diagnostics Point of Care Basic Information
9.13.2 Roche Diagnostics Molecular Diagnostics Point of Care Product Overview
9.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.13.4 Roche Diagnostics Business Overview
9.13.5 Roche Diagnostics Recent Developments
9.14 Nipro Diagnostics
9.14.1 Nipro Diagnostics Molecular Diagnostics Point of Care Basic Information
9.14.2 Nipro Diagnostics Molecular Diagnostics Point of Care Product Overview
9.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.14.4 Nipro Diagnostics Business Overview
9.14.5 Nipro Diagnostics Recent Developments
9.15 Genestat
9.15.1 Genestat Molecular Diagnostics Point of Care Basic Information
9.15.2 Genestat Molecular Diagnostics Point of Care Product Overview
9.15.3 Genestat Molecular Diagnostics Point of Care Product Market Performance
9.15.4 Genestat Business Overview
9.15.5 Genestat Recent Developments
9.16 Meridian Bioscience
9.16.1 Meridian Bioscience Molecular Diagnostics Point of Care Basic Information
9.16.2 Meridian Bioscience Molecular Diagnostics Point of Care Product Overview
9.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product Market Performance
9.16.4 Meridian Bioscience Business Overview
9.16.5 Meridian Bioscience Recent Developments
9.17 Molbio Diagnostics
9.17.1 Molbio Diagnostics Molecular Diagnostics Point of Care Basic Information
9.17.2 Molbio Diagnostics Molecular Diagnostics Point of Care Product Overview
9.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.17.4 Molbio Diagnostics Business Overview
9.17.5 Molbio Diagnostics Recent Developments
9.18 Siemens Healthcare
9.18.1 Siemens Healthcare Molecular Diagnostics Point of Care Basic Information
9.18.2 Siemens Healthcare Molecular Diagnostics Point of Care Product Overview
9.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product Market Performance
9.18.4 Siemens Healthcare Business Overview
9.18.5 Siemens Healthcare Recent Developments
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Molecular Diagnostics Point of Care Basic Information
9.19.2 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Overview
9.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Market Performance
9.19.4 Thermo Fisher Scientific Business Overview
9.19.5 Thermo Fisher Scientific Recent Developments
9.20 Visby Medical
9.20.1 Visby Medical Molecular Diagnostics Point of Care Basic Information
9.20.2 Visby Medical Molecular Diagnostics Point of Care Product Overview
9.20.3 Visby Medical Molecular Diagnostics Point of Care Product Market Performance
9.20.4 Visby Medical Business Overview
9.20.5 Visby Medical Recent Developments
9.21 Wuhan Easy Diagnosis Biomedicine
9.21.1 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Basic Information
9.21.2 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Overview
9.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Market Performance
9.21.4 Wuhan Easy Diagnosis Biomedicine Business Overview
9.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
9.22 Beijing Tiandz
9.22.1 Beijing Tiandz Molecular Diagnostics Point of Care Basic Information
9.22.2 Beijing Tiandz Molecular Diagnostics Point of Care Product Overview
9.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product Market Performance
9.22.4 Beijing Tiandz Business Overview
9.22.5 Beijing Tiandz Recent Developments
9.23 Beijing Content
9.23.1 Beijing Content Molecular Diagnostics Point of Care Basic Information
9.23.2 Beijing Content Molecular Diagnostics Point of Care Product Overview
9.23.3 Beijing Content Molecular Diagnostics Point of Care Product Market Performance
9.23.4 Beijing Content Business Overview
9.23.5 Beijing Content Recent Developments
10 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET FORECAST BY REGION
10.1 Global Molecular Diagnostics Point of Care Market Size Forecast
10.2 Global Molecular Diagnostics Point of Care Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Molecular Diagnostics Point of Care Market Size Forecast by Country
10.2.3 Asia Pacific Molecular Diagnostics Point of Care Market Size Forecast by Region
10.2.4 South America Molecular Diagnostics Point of Care Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Molecular Diagnostics Point of Care by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Molecular Diagnostics Point of Care Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Molecular Diagnostics Point of Care by Type (2025-2030)
11.1.2 Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Molecular Diagnostics Point of Care by Type (2025-2030)
11.2 Global Molecular Diagnostics Point of Care Market Forecast by Application (2025-2030)
11.2.1 Global Molecular Diagnostics Point of Care Sales (K Units) Forecast by Application
11.2.2 Global Molecular Diagnostics Point of Care Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Molecular Diagnostics Point of Care
1.2 Key Market Segments
1.2.1 Molecular Diagnostics Point of Care Segment by Type
1.2.2 Molecular Diagnostics Point of Care Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics Point of Care Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Molecular Diagnostics Point of Care Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET COMPETITIVE LANDSCAPE
3.1 Global Molecular Diagnostics Point of Care Sales by Manufacturers (2019-2024)
3.2 Global Molecular Diagnostics Point of Care Revenue Market Share by Manufacturers (2019-2024)
3.3 Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Diagnostics Point of Care Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Molecular Diagnostics Point of Care Sales Sites, Area Served, Product Type
3.6 Molecular Diagnostics Point of Care Market Competitive Situation and Trends
3.6.1 Molecular Diagnostics Point of Care Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Diagnostics Point of Care Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS POINT OF CARE INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics Point of Care Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS POINT OF CARE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics Point of Care Sales Market Share by Type (2019-2024)
6.3 Global Molecular Diagnostics Point of Care Market Size Market Share by Type (2019-2024)
6.4 Global Molecular Diagnostics Point of Care Price by Type (2019-2024)
7 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics Point of Care Market Sales by Application (2019-2024)
7.3 Global Molecular Diagnostics Point of Care Market Size (M USD) by Application (2019-2024)
7.4 Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
8 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET SEGMENTATION BY REGION
8.1 Global Molecular Diagnostics Point of Care Sales by Region
8.1.1 Global Molecular Diagnostics Point of Care Sales by Region
8.1.2 Global Molecular Diagnostics Point of Care Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Diagnostics Point of Care Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Diagnostics Point of Care Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Diagnostics Point of Care Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Diagnostics Point of Care Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Diagnostics Point of Care Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Molecular Diagnostics Point of Care Basic Information
9.1.2 Abbott Laboratories Molecular Diagnostics Point of Care Product Overview
9.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Molecular Diagnostics Point of Care SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Abaxis
9.2.1 Abaxis Molecular Diagnostics Point of Care Basic Information
9.2.2 Abaxis Molecular Diagnostics Point of Care Product Overview
9.2.3 Abaxis Molecular Diagnostics Point of Care Product Market Performance
9.2.4 Abaxis Business Overview
9.2.5 Abaxis Molecular Diagnostics Point of Care SWOT Analysis
9.2.6 Abaxis Recent Developments
9.3 Bayer Healthcare
9.3.1 Bayer Healthcare Molecular Diagnostics Point of Care Basic Information
9.3.2 Bayer Healthcare Molecular Diagnostics Point of Care Product Overview
9.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product Market Performance
9.3.4 Bayer Healthcare Molecular Diagnostics Point of Care SWOT Analysis
9.3.5 Bayer Healthcare Business Overview
9.3.6 Bayer Healthcare Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Molecular Diagnostics Point of Care Basic Information
9.4.2 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Overview
9.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Becton Dickinson and Company
9.5.1 Becton Dickinson and Company Molecular Diagnostics Point of Care Basic Information
9.5.2 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Overview
9.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product Market Performance
9.5.4 Becton Dickinson and Company Business Overview
9.5.5 Becton Dickinson and Company Recent Developments
9.6 Binx Health
9.6.1 Binx Health Molecular Diagnostics Point of Care Basic Information
9.6.2 Binx Health Molecular Diagnostics Point of Care Product Overview
9.6.3 Binx Health Molecular Diagnostics Point of Care Product Market Performance
9.6.4 Binx Health Business Overview
9.6.5 Binx Health Recent Developments
9.7 BioMerieux
9.7.1 BioMerieux Molecular Diagnostics Point of Care Basic Information
9.7.2 BioMerieux Molecular Diagnostics Point of Care Product Overview
9.7.3 BioMerieux Molecular Diagnostics Point of Care Product Market Performance
9.7.4 BioMerieux Business Overview
9.7.5 BioMerieux Recent Developments
9.8 Co-Diagnostics
9.8.1 Co-Diagnostics Molecular Diagnostics Point of Care Basic Information
9.8.2 Co-Diagnostics Molecular Diagnostics Point of Care Product Overview
9.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.8.4 Co-Diagnostics Business Overview
9.8.5 Co-Diagnostics Recent Developments
9.9 DanaherCorporation
9.9.1 DanaherCorporation Molecular Diagnostics Point of Care Basic Information
9.9.2 DanaherCorporation Molecular Diagnostics Point of Care Product Overview
9.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product Market Performance
9.9.4 DanaherCorporation Business Overview
9.9.5 DanaherCorporation Recent Developments
9.10 Dako
9.10.1 Dako Molecular Diagnostics Point of Care Basic Information
9.10.2 Dako Molecular Diagnostics Point of Care Product Overview
9.10.3 Dako Molecular Diagnostics Point of Care Product Market Performance
9.10.4 Dako Business Overview
9.10.5 Dako Recent Developments
9.11 F. Hoffmann
9.11.1 F. Hoffmann Molecular Diagnostics Point of Care Basic Information
9.11.2 F. Hoffmann Molecular Diagnostics Point of Care Product Overview
9.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product Market Performance
9.11.4 F. Hoffmann Business Overview
9.11.5 F. Hoffmann Recent Developments
9.12 OraSure Technologies
9.12.1 OraSure Technologies Molecular Diagnostics Point of Care Basic Information
9.12.2 OraSure Technologies Molecular Diagnostics Point of Care Product Overview
9.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product Market Performance
9.12.4 OraSure Technologies Business Overview
9.12.5 OraSure Technologies Recent Developments
9.13 Roche Diagnostics
9.13.1 Roche Diagnostics Molecular Diagnostics Point of Care Basic Information
9.13.2 Roche Diagnostics Molecular Diagnostics Point of Care Product Overview
9.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.13.4 Roche Diagnostics Business Overview
9.13.5 Roche Diagnostics Recent Developments
9.14 Nipro Diagnostics
9.14.1 Nipro Diagnostics Molecular Diagnostics Point of Care Basic Information
9.14.2 Nipro Diagnostics Molecular Diagnostics Point of Care Product Overview
9.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.14.4 Nipro Diagnostics Business Overview
9.14.5 Nipro Diagnostics Recent Developments
9.15 Genestat
9.15.1 Genestat Molecular Diagnostics Point of Care Basic Information
9.15.2 Genestat Molecular Diagnostics Point of Care Product Overview
9.15.3 Genestat Molecular Diagnostics Point of Care Product Market Performance
9.15.4 Genestat Business Overview
9.15.5 Genestat Recent Developments
9.16 Meridian Bioscience
9.16.1 Meridian Bioscience Molecular Diagnostics Point of Care Basic Information
9.16.2 Meridian Bioscience Molecular Diagnostics Point of Care Product Overview
9.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product Market Performance
9.16.4 Meridian Bioscience Business Overview
9.16.5 Meridian Bioscience Recent Developments
9.17 Molbio Diagnostics
9.17.1 Molbio Diagnostics Molecular Diagnostics Point of Care Basic Information
9.17.2 Molbio Diagnostics Molecular Diagnostics Point of Care Product Overview
9.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product Market Performance
9.17.4 Molbio Diagnostics Business Overview
9.17.5 Molbio Diagnostics Recent Developments
9.18 Siemens Healthcare
9.18.1 Siemens Healthcare Molecular Diagnostics Point of Care Basic Information
9.18.2 Siemens Healthcare Molecular Diagnostics Point of Care Product Overview
9.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product Market Performance
9.18.4 Siemens Healthcare Business Overview
9.18.5 Siemens Healthcare Recent Developments
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Molecular Diagnostics Point of Care Basic Information
9.19.2 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Overview
9.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Market Performance
9.19.4 Thermo Fisher Scientific Business Overview
9.19.5 Thermo Fisher Scientific Recent Developments
9.20 Visby Medical
9.20.1 Visby Medical Molecular Diagnostics Point of Care Basic Information
9.20.2 Visby Medical Molecular Diagnostics Point of Care Product Overview
9.20.3 Visby Medical Molecular Diagnostics Point of Care Product Market Performance
9.20.4 Visby Medical Business Overview
9.20.5 Visby Medical Recent Developments
9.21 Wuhan Easy Diagnosis Biomedicine
9.21.1 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Basic Information
9.21.2 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Overview
9.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Market Performance
9.21.4 Wuhan Easy Diagnosis Biomedicine Business Overview
9.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
9.22 Beijing Tiandz
9.22.1 Beijing Tiandz Molecular Diagnostics Point of Care Basic Information
9.22.2 Beijing Tiandz Molecular Diagnostics Point of Care Product Overview
9.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product Market Performance
9.22.4 Beijing Tiandz Business Overview
9.22.5 Beijing Tiandz Recent Developments
9.23 Beijing Content
9.23.1 Beijing Content Molecular Diagnostics Point of Care Basic Information
9.23.2 Beijing Content Molecular Diagnostics Point of Care Product Overview
9.23.3 Beijing Content Molecular Diagnostics Point of Care Product Market Performance
9.23.4 Beijing Content Business Overview
9.23.5 Beijing Content Recent Developments
10 MOLECULAR DIAGNOSTICS POINT OF CARE MARKET FORECAST BY REGION
10.1 Global Molecular Diagnostics Point of Care Market Size Forecast
10.2 Global Molecular Diagnostics Point of Care Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Molecular Diagnostics Point of Care Market Size Forecast by Country
10.2.3 Asia Pacific Molecular Diagnostics Point of Care Market Size Forecast by Region
10.2.4 South America Molecular Diagnostics Point of Care Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Molecular Diagnostics Point of Care by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Molecular Diagnostics Point of Care Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Molecular Diagnostics Point of Care by Type (2025-2030)
11.1.2 Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Molecular Diagnostics Point of Care by Type (2025-2030)
11.2 Global Molecular Diagnostics Point of Care Market Forecast by Application (2025-2030)
11.2.1 Global Molecular Diagnostics Point of Care Sales (K Units) Forecast by Application
11.2.2 Global Molecular Diagnostics Point of Care Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Diagnostics Point of Care Market Size Comparison by Region (M USD)
Table 5. Global Molecular Diagnostics Point of Care Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostics Point of Care Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostics Point of Care Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Molecular Diagnostics Point of Care Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Point of Care as of 2022)
Table 10. Global Market Molecular Diagnostics Point of Care Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Molecular Diagnostics Point of Care Sales Sites and Area Served
Table 12. Manufacturers Molecular Diagnostics Point of Care Product Type
Table 13. Global Molecular Diagnostics Point of Care Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Molecular Diagnostics Point of Care
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics Point of Care Market Challenges
Table 22. Global Molecular Diagnostics Point of Care Sales by Type (K Units)
Table 23. Global Molecular Diagnostics Point of Care Market Size by Type (M USD)
Table 24. Global Molecular Diagnostics Point of Care Sales (K Units) by Type (2019-2024)
Table 25. Global Molecular Diagnostics Point of Care Sales Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics Point of Care Market Size (M USD) by Type (2019-2024)
Table 27. Global Molecular Diagnostics Point of Care Market Size Share by Type (2019-2024)
Table 28. Global Molecular Diagnostics Point of Care Price (USD/Unit) by Type (2019-2024)
Table 29. Global Molecular Diagnostics Point of Care Sales (K Units) by Application
Table 30. Global Molecular Diagnostics Point of Care Market Size by Application
Table 31. Global Molecular Diagnostics Point of Care Sales by Application (2019-2024) & (K Units)
Table 32. Global Molecular Diagnostics Point of Care Sales Market Share by Application (2019-2024)
Table 33. Global Molecular Diagnostics Point of Care Sales by Application (2019-2024) & (M USD)
Table 34. Global Molecular Diagnostics Point of Care Market Share by Application (2019-2024)
Table 35. Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
Table 36. Global Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 37. Global Molecular Diagnostics Point of Care Sales Market Share by Region (2019-2024)
Table 38. North America Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 39. Europe Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 41. South America Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Molecular Diagnostics Point of Care Basic Information
Table 44. Abbott Laboratories Molecular Diagnostics Point of Care Product Overview
Table 45. Abbott Laboratories Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Molecular Diagnostics Point of Care SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Abaxis Molecular Diagnostics Point of Care Basic Information
Table 50. Abaxis Molecular Diagnostics Point of Care Product Overview
Table 51. Abaxis Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abaxis Business Overview
Table 53. Abaxis Molecular Diagnostics Point of Care SWOT Analysis
Table 54. Abaxis Recent Developments
Table 55. Bayer Healthcare Molecular Diagnostics Point of Care Basic Information
Table 56. Bayer Healthcare Molecular Diagnostics Point of Care Product Overview
Table 57. Bayer Healthcare Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer Healthcare Molecular Diagnostics Point of Care SWOT Analysis
Table 59. Bayer Healthcare Business Overview
Table 60. Bayer Healthcare Recent Developments
Table 61. Bio-Rad Laboratories Molecular Diagnostics Point of Care Basic Information
Table 62. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Overview
Table 63. Bio-Rad Laboratories Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Becton Dickinson and Company Molecular Diagnostics Point of Care Basic Information
Table 67. Becton Dickinson and Company Molecular Diagnostics Point of Care Product Overview
Table 68. Becton Dickinson and Company Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Becton Dickinson and Company Business Overview
Table 70. Becton Dickinson and Company Recent Developments
Table 71. Binx Health Molecular Diagnostics Point of Care Basic Information
Table 72. Binx Health Molecular Diagnostics Point of Care Product Overview
Table 73. Binx Health Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Binx Health Business Overview
Table 75. Binx Health Recent Developments
Table 76. BioMerieux Molecular Diagnostics Point of Care Basic Information
Table 77. BioMerieux Molecular Diagnostics Point of Care Product Overview
Table 78. BioMerieux Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. BioMerieux Business Overview
Table 80. BioMerieux Recent Developments
Table 81. Co-Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 82. Co-Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 83. Co-Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Co-Diagnostics Business Overview
Table 85. Co-Diagnostics Recent Developments
Table 86. DanaherCorporation Molecular Diagnostics Point of Care Basic Information
Table 87. DanaherCorporation Molecular Diagnostics Point of Care Product Overview
Table 88. DanaherCorporation Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. DanaherCorporation Business Overview
Table 90. DanaherCorporation Recent Developments
Table 91. Dako Molecular Diagnostics Point of Care Basic Information
Table 92. Dako Molecular Diagnostics Point of Care Product Overview
Table 93. Dako Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Dako Business Overview
Table 95. Dako Recent Developments
Table 96. F. Hoffmann Molecular Diagnostics Point of Care Basic Information
Table 97. F. Hoffmann Molecular Diagnostics Point of Care Product Overview
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. F. Hoffmann Business Overview
Table 100. F. Hoffmann Recent Developments
Table 101. OraSure Technologies Molecular Diagnostics Point of Care Basic Information
Table 102. OraSure Technologies Molecular Diagnostics Point of Care Product Overview
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. OraSure Technologies Business Overview
Table 105. OraSure Technologies Recent Developments
Table 106. Roche Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 107. Roche Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 108. Roche Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Roche Diagnostics Business Overview
Table 110. Roche Diagnostics Recent Developments
Table 111. Nipro Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 112. Nipro Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 113. Nipro Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Nipro Diagnostics Business Overview
Table 115. Nipro Diagnostics Recent Developments
Table 116. Genestat Molecular Diagnostics Point of Care Basic Information
Table 117. Genestat Molecular Diagnostics Point of Care Product Overview
Table 118. Genestat Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Genestat Business Overview
Table 120. Genestat Recent Developments
Table 121. Meridian Bioscience Molecular Diagnostics Point of Care Basic Information
Table 122. Meridian Bioscience Molecular Diagnostics Point of Care Product Overview
Table 123. Meridian Bioscience Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Meridian Bioscience Business Overview
Table 125. Meridian Bioscience Recent Developments
Table 126. Molbio Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 127. Molbio Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 128. Molbio Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Molbio Diagnostics Business Overview
Table 130. Molbio Diagnostics Recent Developments
Table 131. Siemens Healthcare Molecular Diagnostics Point of Care Basic Information
Table 132. Siemens Healthcare Molecular Diagnostics Point of Care Product Overview
Table 133. Siemens Healthcare Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Siemens Healthcare Business Overview
Table 135. Siemens Healthcare Recent Developments
Table 136. Thermo Fisher Scientific Molecular Diagnostics Point of Care Basic Information
Table 137. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Overview
Table 138. Thermo Fisher Scientific Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Thermo Fisher Scientific Business Overview
Table 140. Thermo Fisher Scientific Recent Developments
Table 141. Visby Medical Molecular Diagnostics Point of Care Basic Information
Table 142. Visby Medical Molecular Diagnostics Point of Care Product Overview
Table 143. Visby Medical Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Visby Medical Business Overview
Table 145. Visby Medical Recent Developments
Table 146. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Basic Information
Table 147. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Overview
Table 148. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Wuhan Easy Diagnosis Biomedicine Business Overview
Table 150. Wuhan Easy Diagnosis Biomedicine Recent Developments
Table 151. Beijing Tiandz Molecular Diagnostics Point of Care Basic Information
Table 152. Beijing Tiandz Molecular Diagnostics Point of Care Product Overview
Table 153. Beijing Tiandz Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Beijing Tiandz Business Overview
Table 155. Beijing Tiandz Recent Developments
Table 156. Beijing Content Molecular Diagnostics Point of Care Basic Information
Table 157. Beijing Content Molecular Diagnostics Point of Care Product Overview
Table 158. Beijing Content Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Beijing Content Business Overview
Table 160. Beijing Content Recent Developments
Table 161. Global Molecular Diagnostics Point of Care Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Molecular Diagnostics Point of Care Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Molecular Diagnostics Point of Care Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Molecular Diagnostics Point of Care Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Molecular Diagnostics Point of Care Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Molecular Diagnostics Point of Care Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Molecular Diagnostics Point of Care Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Molecular Diagnostics Point of Care Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Molecular Diagnostics Point of Care Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Diagnostics Point of Care Market Size Comparison by Region (M USD)
Table 5. Global Molecular Diagnostics Point of Care Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostics Point of Care Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostics Point of Care Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Molecular Diagnostics Point of Care Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Point of Care as of 2022)
Table 10. Global Market Molecular Diagnostics Point of Care Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Molecular Diagnostics Point of Care Sales Sites and Area Served
Table 12. Manufacturers Molecular Diagnostics Point of Care Product Type
Table 13. Global Molecular Diagnostics Point of Care Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Molecular Diagnostics Point of Care
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics Point of Care Market Challenges
Table 22. Global Molecular Diagnostics Point of Care Sales by Type (K Units)
Table 23. Global Molecular Diagnostics Point of Care Market Size by Type (M USD)
Table 24. Global Molecular Diagnostics Point of Care Sales (K Units) by Type (2019-2024)
Table 25. Global Molecular Diagnostics Point of Care Sales Market Share by Type (2019-2024)
Table 26. Global Molecular Diagnostics Point of Care Market Size (M USD) by Type (2019-2024)
Table 27. Global Molecular Diagnostics Point of Care Market Size Share by Type (2019-2024)
Table 28. Global Molecular Diagnostics Point of Care Price (USD/Unit) by Type (2019-2024)
Table 29. Global Molecular Diagnostics Point of Care Sales (K Units) by Application
Table 30. Global Molecular Diagnostics Point of Care Market Size by Application
Table 31. Global Molecular Diagnostics Point of Care Sales by Application (2019-2024) & (K Units)
Table 32. Global Molecular Diagnostics Point of Care Sales Market Share by Application (2019-2024)
Table 33. Global Molecular Diagnostics Point of Care Sales by Application (2019-2024) & (M USD)
Table 34. Global Molecular Diagnostics Point of Care Market Share by Application (2019-2024)
Table 35. Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
Table 36. Global Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 37. Global Molecular Diagnostics Point of Care Sales Market Share by Region (2019-2024)
Table 38. North America Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 39. Europe Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 41. South America Molecular Diagnostics Point of Care Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Molecular Diagnostics Point of Care Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Molecular Diagnostics Point of Care Basic Information
Table 44. Abbott Laboratories Molecular Diagnostics Point of Care Product Overview
Table 45. Abbott Laboratories Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Molecular Diagnostics Point of Care SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Abaxis Molecular Diagnostics Point of Care Basic Information
Table 50. Abaxis Molecular Diagnostics Point of Care Product Overview
Table 51. Abaxis Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abaxis Business Overview
Table 53. Abaxis Molecular Diagnostics Point of Care SWOT Analysis
Table 54. Abaxis Recent Developments
Table 55. Bayer Healthcare Molecular Diagnostics Point of Care Basic Information
Table 56. Bayer Healthcare Molecular Diagnostics Point of Care Product Overview
Table 57. Bayer Healthcare Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer Healthcare Molecular Diagnostics Point of Care SWOT Analysis
Table 59. Bayer Healthcare Business Overview
Table 60. Bayer Healthcare Recent Developments
Table 61. Bio-Rad Laboratories Molecular Diagnostics Point of Care Basic Information
Table 62. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product Overview
Table 63. Bio-Rad Laboratories Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Becton Dickinson and Company Molecular Diagnostics Point of Care Basic Information
Table 67. Becton Dickinson and Company Molecular Diagnostics Point of Care Product Overview
Table 68. Becton Dickinson and Company Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Becton Dickinson and Company Business Overview
Table 70. Becton Dickinson and Company Recent Developments
Table 71. Binx Health Molecular Diagnostics Point of Care Basic Information
Table 72. Binx Health Molecular Diagnostics Point of Care Product Overview
Table 73. Binx Health Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Binx Health Business Overview
Table 75. Binx Health Recent Developments
Table 76. BioMerieux Molecular Diagnostics Point of Care Basic Information
Table 77. BioMerieux Molecular Diagnostics Point of Care Product Overview
Table 78. BioMerieux Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. BioMerieux Business Overview
Table 80. BioMerieux Recent Developments
Table 81. Co-Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 82. Co-Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 83. Co-Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Co-Diagnostics Business Overview
Table 85. Co-Diagnostics Recent Developments
Table 86. DanaherCorporation Molecular Diagnostics Point of Care Basic Information
Table 87. DanaherCorporation Molecular Diagnostics Point of Care Product Overview
Table 88. DanaherCorporation Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. DanaherCorporation Business Overview
Table 90. DanaherCorporation Recent Developments
Table 91. Dako Molecular Diagnostics Point of Care Basic Information
Table 92. Dako Molecular Diagnostics Point of Care Product Overview
Table 93. Dako Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Dako Business Overview
Table 95. Dako Recent Developments
Table 96. F. Hoffmann Molecular Diagnostics Point of Care Basic Information
Table 97. F. Hoffmann Molecular Diagnostics Point of Care Product Overview
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. F. Hoffmann Business Overview
Table 100. F. Hoffmann Recent Developments
Table 101. OraSure Technologies Molecular Diagnostics Point of Care Basic Information
Table 102. OraSure Technologies Molecular Diagnostics Point of Care Product Overview
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. OraSure Technologies Business Overview
Table 105. OraSure Technologies Recent Developments
Table 106. Roche Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 107. Roche Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 108. Roche Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Roche Diagnostics Business Overview
Table 110. Roche Diagnostics Recent Developments
Table 111. Nipro Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 112. Nipro Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 113. Nipro Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Nipro Diagnostics Business Overview
Table 115. Nipro Diagnostics Recent Developments
Table 116. Genestat Molecular Diagnostics Point of Care Basic Information
Table 117. Genestat Molecular Diagnostics Point of Care Product Overview
Table 118. Genestat Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Genestat Business Overview
Table 120. Genestat Recent Developments
Table 121. Meridian Bioscience Molecular Diagnostics Point of Care Basic Information
Table 122. Meridian Bioscience Molecular Diagnostics Point of Care Product Overview
Table 123. Meridian Bioscience Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Meridian Bioscience Business Overview
Table 125. Meridian Bioscience Recent Developments
Table 126. Molbio Diagnostics Molecular Diagnostics Point of Care Basic Information
Table 127. Molbio Diagnostics Molecular Diagnostics Point of Care Product Overview
Table 128. Molbio Diagnostics Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Molbio Diagnostics Business Overview
Table 130. Molbio Diagnostics Recent Developments
Table 131. Siemens Healthcare Molecular Diagnostics Point of Care Basic Information
Table 132. Siemens Healthcare Molecular Diagnostics Point of Care Product Overview
Table 133. Siemens Healthcare Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Siemens Healthcare Business Overview
Table 135. Siemens Healthcare Recent Developments
Table 136. Thermo Fisher Scientific Molecular Diagnostics Point of Care Basic Information
Table 137. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product Overview
Table 138. Thermo Fisher Scientific Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Thermo Fisher Scientific Business Overview
Table 140. Thermo Fisher Scientific Recent Developments
Table 141. Visby Medical Molecular Diagnostics Point of Care Basic Information
Table 142. Visby Medical Molecular Diagnostics Point of Care Product Overview
Table 143. Visby Medical Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Visby Medical Business Overview
Table 145. Visby Medical Recent Developments
Table 146. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Basic Information
Table 147. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product Overview
Table 148. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Wuhan Easy Diagnosis Biomedicine Business Overview
Table 150. Wuhan Easy Diagnosis Biomedicine Recent Developments
Table 151. Beijing Tiandz Molecular Diagnostics Point of Care Basic Information
Table 152. Beijing Tiandz Molecular Diagnostics Point of Care Product Overview
Table 153. Beijing Tiandz Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Beijing Tiandz Business Overview
Table 155. Beijing Tiandz Recent Developments
Table 156. Beijing Content Molecular Diagnostics Point of Care Basic Information
Table 157. Beijing Content Molecular Diagnostics Point of Care Product Overview
Table 158. Beijing Content Molecular Diagnostics Point of Care Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Beijing Content Business Overview
Table 160. Beijing Content Recent Developments
Table 161. Global Molecular Diagnostics Point of Care Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Molecular Diagnostics Point of Care Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Molecular Diagnostics Point of Care Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Molecular Diagnostics Point of Care Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Molecular Diagnostics Point of Care Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Molecular Diagnostics Point of Care Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Molecular Diagnostics Point of Care Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Molecular Diagnostics Point of Care Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Molecular Diagnostics Point of Care Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Molecular Diagnostics Point of Care Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Molecular Diagnostics Point of Care Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Molecular Diagnostics Point of Care Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Molecular Diagnostics Point of Care
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics Point of Care Market Size (M USD), 2019-2030
Figure 5. Global Molecular Diagnostics Point of Care Market Size (M USD) (2019-2030)
Figure 6. Global Molecular Diagnostics Point of Care Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics Point of Care Market Size by Country (M USD)
Figure 11. Molecular Diagnostics Point of Care Sales Share by Manufacturers in 2023
Figure 12. Global Molecular Diagnostics Point of Care Revenue Share by Manufacturers in 2023
Figure 13. Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Molecular Diagnostics Point of Care Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics Point of Care Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Molecular Diagnostics Point of Care Market Share by Type
Figure 18. Sales Market Share of Molecular Diagnostics Point of Care by Type (2019-2024)
Figure 19. Sales Market Share of Molecular Diagnostics Point of Care by Type in 2023
Figure 20. Market Size Share of Molecular Diagnostics Point of Care by Type (2019-2024)
Figure 21. Market Size Market Share of Molecular Diagnostics Point of Care by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Molecular Diagnostics Point of Care Market Share by Application
Figure 24. Global Molecular Diagnostics Point of Care Sales Market Share by Application (2019-2024)
Figure 25. Global Molecular Diagnostics Point of Care Sales Market Share by Application in 2023
Figure 26. Global Molecular Diagnostics Point of Care Market Share by Application (2019-2024)
Figure 27. Global Molecular Diagnostics Point of Care Market Share by Application in 2023
Figure 28. Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
Figure 29. Global Molecular Diagnostics Point of Care Sales Market Share by Region (2019-2024)
Figure 30. North America Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 32. U.S. Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Molecular Diagnostics Point of Care Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Molecular Diagnostics Point of Care Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 37. Germany Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Molecular Diagnostics Point of Care Sales Market Share by Region in 2023
Figure 44. China Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 50. South America Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 51. Brazil Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Molecular Diagnostics Point of Care Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Molecular Diagnostics Point of Care Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Molecular Diagnostics Point of Care Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Molecular Diagnostics Point of Care Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Molecular Diagnostics Point of Care Market Share Forecast by Type (2025-2030)
Figure 65. Global Molecular Diagnostics Point of Care Sales Forecast by Application (2025-2030)
Figure 66. Global Molecular Diagnostics Point of Care Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Molecular Diagnostics Point of Care
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics Point of Care Market Size (M USD), 2019-2030
Figure 5. Global Molecular Diagnostics Point of Care Market Size (M USD) (2019-2030)
Figure 6. Global Molecular Diagnostics Point of Care Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics Point of Care Market Size by Country (M USD)
Figure 11. Molecular Diagnostics Point of Care Sales Share by Manufacturers in 2023
Figure 12. Global Molecular Diagnostics Point of Care Revenue Share by Manufacturers in 2023
Figure 13. Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Molecular Diagnostics Point of Care Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics Point of Care Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Molecular Diagnostics Point of Care Market Share by Type
Figure 18. Sales Market Share of Molecular Diagnostics Point of Care by Type (2019-2024)
Figure 19. Sales Market Share of Molecular Diagnostics Point of Care by Type in 2023
Figure 20. Market Size Share of Molecular Diagnostics Point of Care by Type (2019-2024)
Figure 21. Market Size Market Share of Molecular Diagnostics Point of Care by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Molecular Diagnostics Point of Care Market Share by Application
Figure 24. Global Molecular Diagnostics Point of Care Sales Market Share by Application (2019-2024)
Figure 25. Global Molecular Diagnostics Point of Care Sales Market Share by Application in 2023
Figure 26. Global Molecular Diagnostics Point of Care Market Share by Application (2019-2024)
Figure 27. Global Molecular Diagnostics Point of Care Market Share by Application in 2023
Figure 28. Global Molecular Diagnostics Point of Care Sales Growth Rate by Application (2019-2024)
Figure 29. Global Molecular Diagnostics Point of Care Sales Market Share by Region (2019-2024)
Figure 30. North America Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 32. U.S. Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Molecular Diagnostics Point of Care Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Molecular Diagnostics Point of Care Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 37. Germany Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Molecular Diagnostics Point of Care Sales Market Share by Region in 2023
Figure 44. China Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 50. South America Molecular Diagnostics Point of Care Sales Market Share by Country in 2023
Figure 51. Brazil Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Molecular Diagnostics Point of Care Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Molecular Diagnostics Point of Care Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Molecular Diagnostics Point of Care Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Molecular Diagnostics Point of Care Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Molecular Diagnostics Point of Care Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Molecular Diagnostics Point of Care Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Molecular Diagnostics Point of Care Market Share Forecast by Type (2025-2030)
Figure 65. Global Molecular Diagnostics Point of Care Sales Forecast by Application (2025-2030)
Figure 66. Global Molecular Diagnostics Point of Care Market Share Forecast by Application (2025-2030)
